A large Veterans Affairs (VA) clinical trial found that the blood pressure drug chlorthalidone (CTD) was not superior to hydrochlorothiazide (HCTZ) for the prevention of cardiovascular disease or non-cancer death.
Dec 15, 2022
0
19
The number of U.S. deaths dropped this year, but there are still more than there were before the coronavirus hit.
Dec 14, 2022
0
4
It's tempting to follow the latest trend when it comes to health care, but for patients who live with heart failure, some alternative treatments could have serious consequences.
Dec 13, 2022
0
8
Could Paxlovid solve one of the pandemic's biggest puzzles? A new study at Stanford University aims to find out.
Nov 25, 2022
0
28
Two studies published by The BMJ today provide up to date evidence on the effectiveness of both currently licensed and possible COVID-19 treatments under everyday ("real world") conditions, helping to shed more light on whether ...
Nov 16, 2022
0
6
Americans aged 25 to 44—so-called millennials—are dying at significantly higher rates from three leading killers than similarly aged people just 10 years ago, the latest government data shows.
Nov 16, 2022
0
2
The Yoshinori Yoshida laboratory reports the generation of a platform of human heart organoids derived from iPS cells, which they use to test new therapeutic alternatives on cardiac fibrosis. Their study is published in Frontiers ...
Nov 15, 2022
0
5
Researchers at the University of Maryland School of Medicine's (UMSOM) Center for Precision Disease Modeling identified how a specific protein in SARS-CoV-2, the virus responsible for COVID-19, damages heart tissue. They ...
Nov 8, 2022
0
61
A national study led by University of British Columbia (UBC) researchers at the Centre for Cardiovascular Innovation is shedding light on how to more effectively treat atrial fibrillation (AF)—a common heart rhythm problem ...
Nov 7, 2022
0
87
The antiviral pill Paxlovid not only reduces hospitalization and death after catching COVID-19: New research shows it also cuts the chances of long COVID by roughly 25%.
Nov 7, 2022
0
9
